You might also like
Part 2: Clinical Case Study Compendium:
PDF case reports 3 & 4
The impact of gilteritinib in daily practice after intensive chemotherapy and following an ..
View more
Clinical Case Study Compendium:
Video case report 2
Real-World Experiences by Dr. A. de Voeght; Sart Tilman-CHU Liège Video of the 2nd case report
View more
Role of Gilteritinib in the Treatment of Relapsed or Refractory FLT3-Mutated AML¹
Video
Video of case report 3:
In this interview Dr. A. de Voeght (Sart Tilman-CHU Liège, Belgium), discusses his experiences with gilteritinib after intensive chemotherapy within a very frail patient.
Intended for: practitioners hematology
Why: up-to-date knowledge TKI2 related target therapy
When: Watch now
Duration: 4 minutes
1: FMS-like Tyrosine Kinase 3 - Acute Myeloid Leukemia; 2: Hematopoietic Stem Cell Transplantation
MAT-BE-XOS-2026-00008 MRT 2026
AML: Acute Myeloid Leukemia
COPYRIGHT © 2026 ASTELLAS PHARMA B.V. MAT-BE-XOS-2025-00030 - DEC 2025